Image

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Testing Lurbinectedin for young patients with relapsed Ewing Sarcoma.

Recruiting
2-30 years
All
Phase 1/2

Study Overview: This study looks at a treatment called lurbinectedin for young people with Ewing sarcoma, a type of cancer affecting bones or soft tissue. The study has two parts. Phase 1 checks if the treatment is safe and how the body processes it in children with solid tumors. Phase 2 tests if it works well and is safe in children and young adults with Ewing sarcoma.

Key Points:

  • This study involves two phases and participants must be between 2 and 30 years old.
  • Participants must have been previously treated for their cancer and meet various health criteria.
  • Male and female participants must follow specific guidelines to prevent pregnancy during the study.

Important Details: Those who join the study will need to meet specific health and age requirements. They will not be eligible if they have certain medical conditions or have had specific treatments before. Participants cannot have certain infections like Hepatitis B or HIV. The study requires commitment, and participants or guardians must be able to attend scheduled visits and follow study rules.

Study details
    Refractory Ewing Sarcoma
    Relapsed Ewing Sarcoma
    Ewing Sarcoma

NCT05734066

Jazz Pharmaceuticals

26 January 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.